1
|
Wirtz T, Weber T, Kracker S, Sommermann T,
Rajewsky K and Yasuda T: Mouse model for acute Epstein-Barr virus
infection. Proc Natl Acad Sci USA. 113:13821–13826. 2016.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Tsai MH, Lin X, Shumilov A, Bernhardt K,
Feederle R, Poirey R, Kopp-Schneider A, Pereira B, Almeida R and
Delecluse HJ: The biological properties of different Epstein-Barr
virus strains explain their association with various types of
cancers. Oncotarget. 8:10238–10254. 2017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Fujimoto A and Suzuki R: Epstein-barr
virus-associated Post-transplant lymphoproliferative disorders
after hematopoietic stem cell transplantation: Pathogenesis, risk
factors and clinical outcomes. Cancers (Basel). 12:3282020.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Yang Y, Zhu Y, Cao JZ, Zhang YJ, Xu LM,
Yuan ZY, Wu JX, Wang W, Wu T, Lu B, et al: Risk-adapted therapy for
early-stage extranodal nasal-type NK/T-cell lymphoma: Analysis from
a multicenter study. Blood. 126:1424–1432. 15172015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lai J, Tan WJ, Too CT, Choo JA, Wong LH,
Mustafa FB, Srinivasan N, Lim AP, Zhong Y, Gascoigne NR, et al:
Targeting Epstein-Barr virus-transformed B lymphoblastoid cells
using antibodies with T-cell receptor-like specificities. Blood.
128:1396–1407. 2016. View Article : Google Scholar : PubMed/NCBI
|
6
|
Nam YS, Im KI, Kim N, Song Y, Lee JS, Jeon
YW and Cho SG: Down-regulation of intracellular reactive oxygen
species attenuates P-glycoprotein-associated chemoresistance in
Epstein-Barr virus-positive NK/T-cell lymphoma. Am J Transl Res.
11:1359–1373. 2019.PubMed/NCBI
|
7
|
Zhang H, Lu J, Jiao Y, Chen Q, Li M, Wang
Z, Yu Z, Huang X, Yao A, Gao Q, et al: Aspirin inhibits Natural
Killer/T-cell lymphoma by modulation of VEGF expression and
mitochondrial function. Front Oncol. 8:6792019. View Article : Google Scholar : PubMed/NCBI
|
8
|
Chou YC, Lin SJ, Lu J, Yeh TH, Chen CL,
Weng PL, Lin JH, Yao M and Tsai CH: Requirement for LMP1-induced
RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell
proliferation. Blood. 118:1340–1349. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang LW, Jiang S and Gewurz BE:
Epstein-barr virus LMP1-mediated oncogenicity. J Virol.
91:e01718–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
10
|
Xiao L, Hu ZY, Dong X, Tan Z, Li W, Tang
M, Chen L, Yang L, Tao Y, Jiang Y, et al: Targeting Epstein-Barr
virus oncoprotein LMP1-mediated glycolysis sensitizes
nasopharyngeal carcinoma to radiation therapy. Oncogene.
33:4568–4578. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Pal AD, Basak NP, Banerjee AS and Banerjee
S: Epstein-Barr virus latent membrane protein-2A alters
mitochondrial dynamics promoting cellular migration mediated by
Notch signaling pathway. Carcinogenesis. 35:1592–1601. 2014.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Wakisaka N, Kondo S, Yoshizaki T, Murono
S, Furukawa M and Pagano JS: Epstein-Barr virus latent membrane
protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.
Mol Cell Biol. 24:5223–5234. 2004. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lo AK, Lung RW, Dawson CW, Young LS, Ko
CW, Yeung WW, Kang W, To KF and Lo KW: Activation of sterol
regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis
by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1)
promotes cell proliferation and progression of nasopharyngeal
carcinoma. J Pathol. 246:180–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
14
|
Bi XW, Wang H, Zhang WW, Wang JH, Liu WJ,
Xia ZJ, Huang HQ, Jiang WQ, Zhang YJ and Wang L: PD-L1 is
upregulated by EBV-driven LMP1 through NF-κB pathway and correlates
with poor prognosis in natural killer/T-cell lymphoma. J Hematol
Oncol. 9:1092016. View Article : Google Scholar : PubMed/NCBI
|
15
|
Higuchi M, Izumi KM and Kieff E:
Epstein-Barr virus latent-infection membrane proteins are
palmitoylated and raft-associated: Protein 1 binds to the
cytoskeleton through TNF receptor cytoplasmic factors. Proc Natl
Acad Sci USA. 98:4675–4680. 2001. View Article : Google Scholar : PubMed/NCBI
|
16
|
Dudziak D, Kieser A, Dirmeier U,
Nimmerjahn F, Berchtold S, Steinkasserer A, Marschall G,
Hammerschmidt W, Laux G and Bornkamm GW: Latent membrane protein 1
of Epstein-Barr virus induces CD83 by the NF-kappaB signaling
pathway. J Virol. 77:8290–8298. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Feng J, Chen Q, Zhang P, Huang X, Xie W,
Zhang H and Yao P: Latent membrane Protein 1 promotes tumorigenesis
through upregulation of PGC1β signaling pathway. Stem Cell Rev Rep.
17:1486–1499. 2021. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lin J, Puigserver P, Donovan J, Tarr P and
Spiegelman BM: Peroxisome proliferator-activated receptor gamma
coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription
coactivator associated with host cell factor. J Biol Chem.
277:1645–1648. 2002. View Article : Google Scholar : PubMed/NCBI
|
19
|
Lin J, Handschin C and Spiegelman BM:
Metabolic control through the PGC-1 family of transcription
coactivators. Cell Metab. 1:361–370. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Deblois G, Chahrour G, Perry MC,
Sylvain-Drolet G, Muller WJ and Giguere V: Transcriptional control
of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary
gland tumorigenesis. Cancer Res. 70:10277–10287. 2010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Bellafante E, Morgano A, Salvatore L,
Murzilli S, Di Tullio G, D'Orazio A, Latorre D, Villani G and
Moschetta A: PGC-1β promotes enterocyte lifespan and tumorigenesis
in the intestine. Proc Natl Acad Sci USA. 111:E4523–E4531. 2014.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Piccinin E, Villani G and Moschetta A:
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: The
role of PGC1 coactivators. Nat Rev Gastroenterol Hepatol.
16:160–174. 2019. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zhang H, Li L, Chen Q, Li M, Feng J, Sun
Y, Zhao R, Zhu Y, Lv Y, Zhu Z, et al: PGC1β regulates multiple
myeloma tumor growth through LDHA-mediated glycolytic metabolism.
Mol Oncol. 12:1579–1595. 2018. View Article : Google Scholar : PubMed/NCBI
|
24
|
Chen X, Lv Y, Sun Y, Zhang H, Xie W, Zhong
L, Chen Q, Li M, Li L, Feng J, et al: PGC1β regulates breast tumor
growth and metastasis by SREBP1-mediated HKDC1 expression. Front
Oncol. 9:2902019. View Article : Google Scholar : PubMed/NCBI
|
25
|
Bodnar AG, Ouellette M, Frolkis M, Holt
SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S and
Wright WE: Extension of life-span by introduction of telomerase
into normal human cells. Science. 279:349–352. 1998. View Article : Google Scholar : PubMed/NCBI
|
26
|
Kong D, Zhan Y, Liu Z, Ding T, Li M, Yu H,
Zhang L, Li H, Luo A, Zhang D, et al: SIRT1-mediated ERβ
suppression in the endothelium contributes to vascular aging. Aging
Cell. 15:1092–1102. 2016. View Article : Google Scholar : PubMed/NCBI
|
27
|
Lan K, Verma SC, Murakami M, Bajaj B and
Robertson ES: Epstein-Barr Virus (EBV): Infection, propagation,
quantitation, and storage. Curr Protoc Microbiol. Chapter 14: Unit
14E.2. 2007. View Article : Google Scholar
|
28
|
Gong LJ, Wang XY, Gu WY and Wu X:
Pinocembrin ameliorates intermittent hypoxia-induced
neuroinflammation through BNIP3-dependent mitophagy in a murine
model of sleep apnea. J Neuroinflammation. 17:3372020. View Article : Google Scholar : PubMed/NCBI
|
29
|
Ogino S, Kawasaki T, Brahmandam M, Cantor
M, Kirkner GJ, Spiegelman D, Makrigiorgos GM, Weisenberger DJ,
Laird PW, Loda M and Fuchs CS: Precision and performance
characteristics of bisulfite conversion and real-time PCR
(MethyLight) for quantitative DNA methylation analysis. J Mol
Diagn. 8:209–217. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Eads CA, Danenberg KD, Kawakami K, Saltz
LB, Blake C, Shibata D, Danenberg PV and Laird PW: MethyLight: A
high-throughput assay to measure DNA methylation. Nucleic Acids
Res. 28:E322000. View Article : Google Scholar : PubMed/NCBI
|
31
|
Nosho K, Irahara N, Shima K, Kure S,
Kirkner GJ, Schernhammer ES, Hazra A, Hunter DJ, Quackenbush J,
Spiegelman D, et al: Comprehensive biostatistical analysis of CpG
island methylator phenotype in colorectal cancer using a large
population-based sample. PLoS One. 3:e36982008. View Article : Google Scholar : PubMed/NCBI
|
32
|
Zou Y, Lu Q, Zheng D, Chu Z, Liu Z, Chen
H, Ruan Q, Ge X, Zhang Z, Wang X, et al: Prenatal levonorgestrel
exposure induces autism-like behavior in offspring through ERβ
suppression in the amygdala. Mol Autism. 8:462017. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zhang H, Li L, Li M, Huang X, Xie W, Xiang
W and Yao P: Combination of betulinic acid and chidamide inhibits
acute myeloid leukemia by suppression of the HIF1α pathway and
generation of reactive oxygen species. Oncotarget. 8:94743–94758.
2017. View Article : Google Scholar : PubMed/NCBI
|
34
|
Ramezani G, Norouzi A, Arabshahi SKS,
Sohrabi Z, Zazoli AZ, Saravani S and Pourbairamian G: Study of
medical students' learning approaches and their association with
academic performance and problem-solving styles. J Educ Health
Promot. 11:2522022. View Article : Google Scholar : PubMed/NCBI
|
35
|
Vargas-Ayala RC, Jay A, Manara F, Maroui
MA, Hernandez-Vargas H, Diederichs A, Robitaille A, Sirand C,
Ceraolo MG, Romero-Medina MC, et al: Interplay between the
Epigenetic Enzyme Lysine (K)-Specific demethylase 2B and
Epstein-Barr Virus Infection. J Virol. 93:e00273–19. 2019.
View Article : Google Scholar : PubMed/NCBI
|
36
|
Shi F, Zhou M, Shang L, Du Q, Li Y, Xie L,
Liu X, Tang M, Luo X, Fan J, et al: EBV(LMP1)-induced metabolic
reprogramming inhibits necroptosis through the hypermethylation of
the RIP3 promoter. Theranostics. 9:2424–2438. 2019. View Article : Google Scholar : PubMed/NCBI
|
37
|
Martin KA, Lupey LN and Tempera I:
Epstein-Barr Virus oncoprotein LMP1 mediates epigenetic changes in
host gene expression through PARP1. J Virol. 90:8520–8530. 2016.
View Article : Google Scholar : PubMed/NCBI
|
38
|
Leonard S, Wei W, Anderton J, Vockerodt M,
Rowe M, Murray PG and Woodman CB: Epigenetic and transcriptional
changes which follow Epstein-Barr virus infection of germinal
center B cells and their relevance to the pathogenesis of Hodgkin's
lymphoma. J Virol. 85:9568–9577. 2011. View Article : Google Scholar : PubMed/NCBI
|
39
|
Chen Z, Liu W, Zhang W, Ye Y, Guan P, Gao
L and Zhao S: Chronic active Epstein-Barr Virus infection of
T/NK-cell type mimicking classic hodgkin lymphoma:
Clinicopathologic and genetic features of 8 cases supporting a
variant with ‘Hodgkin/Reed-Sternberg-like’ cells of NK phenotype.
Am J Surg Pathol. 43:1611–1621. 2019. View Article : Google Scholar : PubMed/NCBI
|
40
|
Rodrigues T and Ferraz LS: Therapeutic
potential of targeting mitochondrial dynamics in cancer. Biochem
Pharmacol. 182:1142822020. View Article : Google Scholar : PubMed/NCBI
|
41
|
Kelly DP and Scarpulla RC: Transcriptional
regulatory circuits controlling mitochondrial biogenesis and
function. Genes Dev. 18:357–368. 2004. View Article : Google Scholar : PubMed/NCBI
|
42
|
Xu J, Ji L, Ruan Y, Wan Z, Lin Z, Xia S,
Tao L, Zheng J, Cai L, Wang Y, et al: UBQLN1 mediates sorafenib
resistance through regulating mitochondrial biogenesis and ROS
homeostasis by targeting PGC1β in hepatocellular carcinoma. Signal
Transduct Target Ther. 6:1902021. View Article : Google Scholar : PubMed/NCBI
|
43
|
Chang CY, Kazmin D, Jasper JS, Kunder R,
Zuercher WJ and McDonnell DP: The metabolic regulator ERRalpha, a
downstream target of HER2/IGF-1R, as a therapeutic target in breast
cancer. Cancer Cell. 20:500–510. 2011. View Article : Google Scholar : PubMed/NCBI
|
44
|
Deblois G, St-Pierre J and Giguere V: The
PGC-1/ERR signaling axis in cancer. Oncogene. 32:3483–3490. 2013.
View Article : Google Scholar : PubMed/NCBI
|
45
|
Chen Q, Feng J, Wu J, Yu Z, Zhang W, Chen
Y, Yao P and Zhang H: HKDC1 C-terminal based peptides inhibit
extranodal natural killer/T-cell lymphoma by modulation of
mitochondrial function and EBV suppression. Leukemia. 34:2736–2748.
2020. View Article : Google Scholar : PubMed/NCBI
|